文献速递乳腺乳腺X线USMR

原发性乳腺癌治疗后的影像学监测

Imaging Surveillance After Primary Breast Cancer Treatment.
PubMed 文献 · AJR Am J Roentgenol · 2017-01-11

本文综述了散发性单侧原发性乳腺癌治疗后影像学监测的证据,指出指南一致支持每年乳腺X线摄影,数字乳腺断层合成(DBT)在减少召回率方面显示潜力,全乳超声不被多数指南支持,MRI监测获益人群尚需进一步研究。

要点

  • 指南一致支持原发性乳腺癌治疗后每年乳腺X线摄影监测。
  • DBT作为一线监测手段较标准数字乳腺X线摄影显著降低召回率,但仅一项已发表研究。
  • 多数指南不支持全乳超声用于乳腺癌监测,MRI监测获益人群特征需进一步研究。

核心结论

  • 证据支持乳腺X线摄影用于原发性乳腺癌治疗后的监测;DBT作为潜在替代标准数字乳腺X线摄影的一线监测手段最有前景;多数指南不支持全乳超声监测,MRI监测获益人群需进一步研究。

研究设计与样本

  • 综述,回顾支持原发性乳腺癌治疗后监测的乳腺影像检查方式性能与有效性的证据。

诊断标准与关键数值

  • 指南一致支持原发性乳腺癌治疗后每年乳腺X线摄影监测。
  • DBT较标准数字乳腺X线摄影显著降低召回率,基于一项已发表研究。
  • 多数指南不支持全乳超声用于乳腺癌监测。

临床应用与阅片要点

  • 指南支持乳腺X线摄影用于原发性乳腺癌治疗后监测。
  • 指南在监测起始时间、间隔和终止方面存在差异。
  • DBT作为潜在替代标准数字乳腺X线摄影的一线监测手段最有前景。
  • 多数指南不支持全乳超声用于乳腺癌监测。
  • MRI监测获益女性特征需进一步研究。

局限性

  • DBT降低召回率的证据仅来自一项已发表研究。
  • MRI监测获益女性特征需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Current clinical guidelines are consistent in supporting annual mammography for women after treatment of primary breast cancer. Surveillance imaging beyond standard digital mammography, including digital breast tomosynthesis (DBT), breast ultrasound, and MRI, may improve outcomes. This article reviews the evidence on the performance and effectiveness of breast imaging modalities available for surveillance after treatment of sporadic unilateral primary breast cancer and identifies additional factors to be considered when selecting an imaging surveillance regimen.

CONCLUSION: Evidence review supports the use of mammography for surveillance after primary breast cancer treatment. Variability exists in guideline recommendations for surveillance initiation, interval, and cessation. DBT offers the most promise as a potential modality to replace standard digital mammography as a front-line surveillance test; a single published study to date has shown a significant decrease in recall rates compared with standard digital mammography alone. Most guidelines do not support the use of whole-breast ultrasound in breast cancer surveillance, and further studies are needed to define the characteristics of women who may benefit from MRI surveillance. The emerging evidence about surveillance imaging outcomes suggests that additional factors, including patient and imaging characteristics, tumor biology and gene expression profile, and choice of treatment, warrant consideration in selecting personalized posttreatment imaging surveillance regimens.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Lam DL, Houssami N, Lee JM, et al. Imaging Surveillance After Primary Breast Cancer Treatment. AJR Am J Roentgenol. 2017. PMID: 28075622. doi:10.2214/AJR.16.16300

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。